Evolving variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become a growing concern worldwide for their rapid transmission
Continue reading »
Home »
FDA authorizes use of Symbiotica COVID-19 Self-Collected Antibody Test System
The U.S. Food and Drug Administration today announced it has issued an emergency use authorization (EUA) for the Symbiotica COVID-19
Continue reading »
New prototype COVID-19 antibody test developed
A new COVID-19 antibody test superior to those currently available has been developed by researchers at the University of Aberdeen
Continue reading »
mRNA COVID-19 vaccines show high efficacy in pregnancy and lactation
A number of vaccines have reached the emergency use authorization (EUA) stage and have been administered to millions of people
Continue reading »
Researchers explore relationship between maternal microbiota and neonatal antibody response
A healthy system of gut bacteria, or microbiota, is crucial to health: Gut bacteria not only aid with digestion, but
Continue reading »
Basigin does not facilitate SARS-CoV-2 entry, say researchers
A study recently conducted at the Jenner Institute, University of Oxford, UK, has investigated the significance of a transmembrane glycoprotein
Continue reading »
Bavencio
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BAVENCIO® This medicine is subject to additional
Continue reading »
Demand is low for COVID-19 antibody drugs but shortages loom
U.S. health officials are seeing an astonishing lack of demand for COVID-19 medicines that may help keep infected people out
Continue reading »
New saliva-based antibody test for SARS-CoV-2 highly accurate in initial study
A new saliva-based test developed by a team at Johns Hopkins Bloomberg School of Public Health has been found to
Continue reading »
Regeneron’s COVID-19 Outpatient Trial Prospectively Demonstrates that REGN-COV2 Antibody Cocktail Significantly Reduced Virus Levels and Need for Further Medical Attention
TARRYTOWN, N.Y., Oct. 28, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive, prospective results from an ongoing Phase 2/3 seamless trial
Continue reading »